iBet uBet web content aggregator. Adding the entire web to your favor.

Link to original content: https://pubmed.ncbi.nlm.nih.gov/19264689

Asthma - PubMed

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2009 Mar 5;360(10):1002-14.

doi: 10.1056/NEJMra0804579.

Asthma

Christopher H Fanta¹

Affiliations

Affiliation

¹ Partners Asthma Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. cfanta@partners.org

PMID: 19264689
DOI: 10.1056/NEJMra0804579

Review

Asthma

Christopher H Fanta. N Engl J Med. 2009.

. 2009 Mar 5;360(10):1002-14.

doi: 10.1056/NEJMra0804579.

Author

Christopher H Fanta¹

Affiliation

¹ Partners Asthma Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. cfanta@partners.org

PMID: 19264689
DOI: 10.1056/NEJMra0804579

Erratum in

N Engl J Med. 2009 Apr 16;360(16):1685
N Engl J Med. 2009 Sep 10;361(11):1123

No abstract available

PubMed Disclaimer

Comment in

Drug therapy for asthma.
Rust G. Rust G. N Engl J Med. 2009 Jun 11;360(24):2578; author reply 2579. doi: 10.1056/NEJMc090694. N Engl J Med. 2009. PMID: 19516041 No abstract available.
Drug therapy for asthma.
Hilmy NM. Hilmy NM. N Engl J Med. 2009 Jun 11;360(24):2578-9; author reply 2579. N Engl J Med. 2009. PMID: 19522048 No abstract available.
Drug therapy for asthma.
Farel RM. Farel RM. N Engl J Med. 2009 Jun 11;360(24):2579; author reply 2579. N Engl J Med. 2009. PMID: 19522049 No abstract available.

Similar articles

Changes in recommended treatments for mild and moderate asthma.
Redding GJ, Stoloff SW. Redding GJ, et al. J Fam Pract. 2004 Sep;53(9):692-700. J Fam Pract. 2004. PMID: 15353157 Review. No abstract available.
[Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
Diamant Z, Dekhuijzen PN. Diamant Z, et al. Ned Tijdschr Geneeskd. 2003 Aug 30;147(35):1681-5. Ned Tijdschr Geneeskd. 2003. PMID: 14513539 Review. Dutch.
[Diagnostics and therapy of asthma].
[No authors listed] [No authors listed] Duodecim. 2000;116(22):2568-84. Duodecim. 2000. PMID: 12053356 Finnish. No abstract available.
[Asthma: current therapeutic approach].
Bononi F, Mazzone M, Portale G, Forte P, Falcone C, Silveri NG. Bononi F, et al. Recenti Prog Med. 2005 Oct;96(10):494-8. Recenti Prog Med. 2005. PMID: 16491774 Review. Italian.
[Treatment of bronchial asthma in adults. Current advances].
Caramori G, Contoli M, Papi A. Caramori G, et al. Recenti Prog Med. 2009 Apr;100(4):171-9. Recenti Prog Med. 2009. PMID: 19554915 Review. Italian.

See all similar articles

Cited by

Distinctive CD39⁺CD9⁺ lung interstitial macrophages suppress IL-23/Th17-mediated neutrophilic asthma by inhibiting NETosis.
Han S, Kim B, Hyeon DY, Jeong D, Ryu J, Nam JS, Choi YH, Kim BR, Park SC, Chung YW, Shin SJ, Lee JY, Kim JK, Park J, Lee SW, Kim TB, Cheon JH, Cho HJ, Kim CH, Yoon JH, Hwang D, Ryu JH. Han S, et al. Nat Commun. 2024 Oct 4;15(1):8628. doi: 10.1038/s41467-024-53038-2. Nat Commun. 2024. PMID: 39366998 Free PMC article.
Allergic asthma is a risk factor for human cardiovascular diseases.
Guo J, Zhang Y, Liu T, Levy BD, Libby P, Shi GP. Guo J, et al. Nat Cardiovasc Res. 2022 May;1(5):417-430. doi: 10.1038/s44161-022-00067-z. Epub 2022 May 16. Nat Cardiovasc Res. 2022. PMID: 39195946 Review.
A new Anticalin protein for IL-23 inhibits non-type 2 allergen-driven mouse lung inflammation and airway hyperresponsiveness.
Brüggemann TR, Krishnamoorthy N, Hagner M, Matschiner G, Jaquin T, Tavares LP, Peh HY, Levy BD. Brüggemann TR, et al. Am J Physiol Lung Cell Mol Physiol. 2024 Nov 1;327(5):L624-L633. doi: 10.1152/ajplung.00295.2023. Epub 2024 Aug 6. Am J Physiol Lung Cell Mol Physiol. 2024. PMID: 39104317
Evaluation of oral nano-curcumin efficacy on respiratory function and quality of life in patients with bronchial non-atopic asthma: A randomized controlled trial.
Lari SM, Mohamadpour AH, Attaran D, Jafari M, Arasteh O, Emadzadeh M, Mozdourian M, Attaran S, Javidarabshahi Z. Lari SM, et al. Avicenna J Phytomed. 2024 Mar-Apr;14(2):229-241. doi: 10.22038/AJP.2023.22826. Avicenna J Phytomed. 2024. PMID: 38966624 Free PMC article.
Heat-killed Akkermansia muciniphila ameliorates allergic airway inflammation in mice.
Yoon SA, Lim Y, Byeon HR, Jung J, Ma S, Hong MG, Kim D, Song EJ, Nam YD, Seo JG, Lee SN. Yoon SA, et al. Front Microbiol. 2024 May 9;15:1386428. doi: 10.3389/fmicb.2024.1386428. eCollection 2024. Front Microbiol. 2024. PMID: 38784796 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information